Navigation Links
Cord Blood America Announces First Quarter Financial Results
Date:5/21/2012

loss from operations was reduced by approximately $1.2 million from the first quarter of 2011 to the first quarter of 2012.  It is important to note this number does include depreciation and amortization, as well as some interest income.  We are concentrating on a positive EBITDA performance for our operations, as we believe it is a critical component to creating company value.  We will be disciplined with each dollar spent.   We will not be biased to post growth just for growth.  As we dissect the business, we always will assess the cost to obtain an additional dollar of revenue. 

Finally, we continue to assess our approximately $2.3 million in existing principal debt versus an outstanding share count that has reached the ceiling of the authorized.  We are exploring different alternatives.  We recognize that in light of these debt obligations the cash value from the reoccurring sample base alone should provide more than ample coverage, thus providing us the opportunity to execute a viable business strategy. 

"The next 90-120 days will be very tactical as we evaluate each and every segment of the business, with the goal of ensuring a financially sound footprint, along with a stable platform to grow.  We remain excited about the possibilities, but we also understand this enthusiasm will only carry momentum with positive results," Mr. Vicente said. 

Cord Blood America
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
2. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
3. Limbs saved by menstrual blood stem cells
4. Sanofi Aventis : New Study Results Support the "Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
5. Human Trial Results Show Plant Extract Tops Drug at Regulating Blood Sugar Levels; Huge Market Seen for Newly Developed Food Additive Emulin™
6. No Blood Needed Thanks to Innovative Medical Technology
7. The Modern DeBakey VAD™ To Be Introduced For the First Time in the U.S. : HeartAssist 5™ Pediatric VAD Features Industry Exclusive Direct Blood Flow Measurement System
8. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
9. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
10. American Red Cross Expands Agreement for Strategic Blood Management(TM) Services from Strategic Healthcare Group LLC
11. China Biologic Products Enters Into Agreement to Acquire 35% Interest in Xian Huitian Blood Products Co., Ltd. and Introduces Preliminary Guidance for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 OTC Markets Group ... a biotechnology company, on its approval to list ... on OTCQX®, the best marketplace for established U.S. ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ... execution of its growth strategy and achievement of ...
(Date:8/21/2014)... KONG , Aug. 21, 2014  China Cord Blood ... announced its plan to release financial results for the ... 28, 2014, after market close in the US.  ... at 8:00 a.m. ET on Friday, August 29, 2014 ... overview of the Company,s recent developments, followed by a ...
(Date:8/21/2014)... VIEW, Calif. , Aug. 21, 2014 /PRNewswire/ ... properties and behaviors based on external stimuli such ... poised to have a disruptive effect in multiple ... revolutionize the business landscape by printing objects ranging ... aerospace and automotive sectors. Logo - ...
(Date:8/21/2014)... Pursuit Solutions ( http://www.pursuit-solutions.com ), a ... for Life Sciences sales and marketing organizations, announced ... Commercial Sales Models” by Peter Robinson, co-founder and ... examines some innovative models used to improve sales ... the pharmaceutical market. Robinson grades the industry on ...
Breaking Biology Technology:OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 2Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 3Frost & Sullivan: 4-D Printing to Usher in Age of Low-Labor, Fast-Paced Product Manufacturing 4Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2
... China, April 8 Sinobiopharma Pharmaceutical Group (OTC ... appointment of Ms. Yan Tan as Director of ... Ltd., Netherlands. She served as a China-based Unit ... to Schering-Plough. Prior to Organon, Ms. Tan held ...
... the simplicity of protein precipitation with the ... of phospholipids and proteins from biological samples ... Supelco, a division of Sigma-Aldrich (Nasdaq: ... supplier of chromatography products for analysis and ...
... April 8 ImQuest Life Sciences presented their ... their novel small molecule piperazine compound for the ... Therapeutics meeting held in Whistler, British Columbia. The ... lead microtubule inhibitor, IQP-0304. The piperazines demonstrate potent ...
Cached Biology Technology:Sinobiopharma, Inc. Appoints New Director of Marketing 2HybridSPE(TM)-Precipitation Technology Wins SelectScience.net 2009 Scientists' Choice Award for Best New Separations Product in 2008 2HybridSPE(TM)-Precipitation Technology Wins SelectScience.net 2009 Scientists' Choice Award for Best New Separations Product in 2008 3ImQuest Presentation at Keystone Symposium Focuses on Advancements in Their Cancer Research and Development Program 2
(Date:8/21/2014)... New feeding tube connectors, designed by an international standards ... safety. , According to an invited review published in ... ( NCP ), the official journal of the ... new connectors will greatly reduce the occurrence of misconnection ... , Small-bore connectors, which are used to join medical ...
(Date:8/21/2014)... researchers at Louisiana Tech University has developed ... 3D printers and materials to fabricate custom ... chemotherapeutic compounds for targeted drug delivery. , ... research faculty from Louisiana Tech,s biomedical engineering ... filament extruders that can make medical-quality 3D ...
(Date:8/21/2014)... Australian National University (ANU) team has successfully replicated one ... for biological systems powered by sunlight which could manufacture ... so is sunlight. It is an exciting prospect to ... and safely," said Dr Kastoori Hingorani, from the ARC ... Research School of Biology. , Hydrogen offers potential as ...
Breaking Biology News(10 mins):New feeding tube connectors will improve patient safety 2Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3Water and sunlight the formula for sustainable fuel 2
... Who:, , Nobel Laureate Martin Chalfie of Columbia ... Incoming ASCB president Sandra Schmid of Scripps Research Institute, ... as moderator What: An informal, good-natured, and ... format, this experimental program will be targeted to young ...
... 2010 The human body is home to a complex ... in both health and disease. Viruses can attack and ... about how this might influence human health. In a ... www.genome.org ), scientists have performed the first metagenomic analysis of ...
... with type 1 diabetes may be able to grow ... Georgetown University Medical Center (GUMC) researchers who presented their ... 50th annual meeting in Philadelphia. Their laboratory and animal ... stem cells (SSCs) extracted from testicular tissue can morph ...
Cached Biology News:Tracing microbes between individuals towards personalized oral health care 2'Grow your own transplant' may be possible for men with type 1 diabetes 2
... Cell Dissociation Buffers are membrane-filtered isotonic ... chelating agents and cell-conditioning agents in ... salt solution or Ca2+- and ... of mammalian cells from support substrates ...
Request Info...
Request Info...
...
Biology Products: